Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2004 1
2006 3
2008 2
2009 2
2010 2
2011 6
2012 7
2013 4
2014 3
2015 2
2016 6
2017 2
2018 10
2019 27
2020 21
2021 17
2022 17
2023 19
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Munoz-Camelo
Page 1
Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study.
Barraclough A, Agrawal S, Talaulikar D, Chong G, Yoo E, Cheah CY, Franco N, Nguyen B, Mutsando H, Tahir F, Trotman J, Huang J, Keane C, Lincoln M, Cochrane T, Johnston AM, Dickinson M, Opat S, McQuilten ZK, Wood EM, St George G, Hawkes EA. Barraclough A, et al. Among authors: tahir f. Haematologica. 2024 Mar 7. doi: 10.3324/haematol.2023.284538. Online ahead of print. Haematologica. 2024. PMID: 38450504 Free article.
Surface-Enhanced Raman Scattering (SERS) in Combination with PCA and PLS-DA for the Evaluation of Antibacterial Activity of 1-Isopentyl-3-pentyl-1H-imidazole-3-ium Bromide against Bacillus subtilis.
Tahir F, Kamran A, Majeed MI, Alghamdi AA, Javed MR, Nawaz H, Iqbal MA, Tahir M, Tariq A, Rashid N, Shahid U, Hassan A, Shoukat US. Tahir F, et al. ACS Omega. 2024 Jan 30;9(6):6861-6872. doi: 10.1021/acsomega.3c08196. eCollection 2024 Feb 13. ACS Omega. 2024. PMID: 38371792 Free PMC article.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
143 results